A bionic eye provided ‘substantial improvement’ in the functional vision and quality of life of four patients with retinitis pigmentosa, reported researchers who conducted Australia’s first clinical trial of the device.
A new study showed fenofibrate, a drug traditionally used to lower cholesterol, can significantly reduce the progression of diabetic retinopathy (DR).
A randomised, controlled trial of primary open-angle glaucoma (POAG) patients showed their intraocular pressures (IOP) were significantly elevated when they experienced stress. The study, publ
Myopia in children rapidly increased during the Covid-19 pandemic, then temporarily decreased and subsequently rebounded, a new survey of schoolchildren in China found. Examining uncorrected v
Auckland-based Eye Surgery Associates has appointed Margot Goldsmith as its new practice manager.
Children with uveitis should be followed up for cataracts, reported a Taiwanese research team on the back of a retrospective cohort study published in JAMA Network Open.
A recent UK study comparing patient and eyecare professional (ECP) views about information provided on age-related macular degeneration (AMD) and diabetic macular oedema found a distinct difference between what ECPs think they tell patients and what patients remember.
Researchers in China have found 15 minutes of intense sunlight exposure restored fundus blood flow perfusion (BFP) in young myopes following an hour of indoor near-work.
Four-year data from Genentech’s Rhone-X extension study showed 80% of participants with diabetic macular oedema (DMO) treated with Vabysmo (faricimab-svoa) extended their treatment intervals to every
French surgical-robotics company Acusurgical announced the successful completion of its first retinal surgery using the bi-manual ophthalmology surgical robot, Luca, for vitrectomy procedures.
Teaming up with the largest agriculture event in the Southern Hemisphere, Macular Degeneration New Zealand (MDNZ) and other health advocates attracted more than 25,000 visitors at the Fieldays’ Health & Wellness Hub in Mystery Creek, Hamilton.
As prescriptions for semaglutide-containing weight-loss drugs increase around the world, a US study has revealed a higher risk of nonarteritic anterior ischemic optic neuropathy (NAION) when taking this type of medication.
